Festus Doyin Adu
Department of Virology, College of Medicine, University of Ibadan, Nigeria
Jane Iber
Division of Molecular Virology, Center for Disease Control and Prevention, Atlanta Georgia, USA.
Tekena Harry
Dept of Immunology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria
Cara Burns
Division of Molecular Virology, Center for Disease Control and Prevention, Atlanta Georgia, USA
Oluseyi Oyedele
Department of Virology, College of Medicine, University of Ibadan, Nigeria
Johnson Adekunle Adeniji
Department of Virology, College of Medicine, University of Ibadan, Nigeria
Mubarak Ossei-Kwasi
Noguchi Memorial Institute for Medical Research Legon Ghana.
David Kilpatrick
Division of Molecular Virology, Center for Disease Control and Prevention, Atlanta Georgia, USA
Oyewale Tomori
WHO Regional Office Harare Zimbabwe
Olen Kew
Division of Molecular Virology, Center for Disease Control and Prevention, Atlanta Georgia, USA
Abstract
A total of 34 sabin strains of the poliovirus isolated from 22 children with 60-day follow-up residual acute flaccid paralysis (AFP) were genetically characterized and screened for any form of recombination. Sequence analysis of the 906-nucleotide capsid showed that all the isolates were similar to their original sabin serotypes, however two of the viruses had drifted in their 3D noncapsid regions toward a sabin-sabin and sabin-nonpolio entero combination. Routine immunization in Nigeria is low and in spite of the increase in the frequency of supplemental immunizations, a lot of children are still inadequately immunized, which may be the reason for our observation in this study. Although we are not dealing with a case of circulating vaccine derived poliovirus (cVDPV) yet, if the above condition persists, the advent of cVDVP may not be too far. There is therefore the need to maintain a high quality mass immunization and sustained routine immunization.
Key words: Poliovirus, sequence, crossover, non polio enterovirus, recombination, genome, Sabin-like, vaccine, Nigeria.
African Journal of Biotechnology Vol.2(11) 2003: 460-464